Education
About Us
Working with TipRanks
Follow Us
Jubilant Pharmova Limited (IN:JUBLPHARMA)
:JUBLPHARMA
JUBLPHARMA Stock Chart & Stats
₹1086.95
₹15.25(1.49%)
At close: 4:00 PM EST
₹1086.95
₹15.25(1.49%)
Day’s Range― - ―
52-Week Range₹823.70 - ₹1,263.90
Previous CloseN/A
Volume282.20K
Average Volume (3M)7.42K
Market Cap
₹188.15B
Enterprise Value₹203.20B
Total Cash (Recent Filing)₹10.89B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)39.2
Beta1.35
Next Earnings
Jan 30, 2026EPS Estimate
9.6Last Dividend Ex-Date
Jul 25, 2025Dividend Yield0.46%
Share Statistics
EPS (TTM)7.85
Shares Outstanding159,281,140
10 Day Avg. Volume4,911
30 Day Avg. Volume7,424
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)2.33
Price to Sales (P/S)2.01
P/FCF Ratio-334.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Jubilant Pharmova Limited News
JUBLPHARMA FAQ
What was Jubilant Pharmova Limited’s price range in the past 12 months?
Jubilant Pharmova Limited lowest stock price was ₹823.70 and its highest was ₹1263.90 in the past 12 months.
What is Jubilant Pharmova Limited’s market cap?
Jubilant Pharmova Limited’s market cap is ₹188.15B.
When is Jubilant Pharmova Limited’s upcoming earnings report date?
Jubilant Pharmova Limited’s upcoming earnings report date is Jan 30, 2026 which is in 64 days.
How were Jubilant Pharmova Limited’s earnings last quarter?
Jubilant Pharmova Limited released its earnings results on Oct 31, 2025. The company reported ₹7.85 earnings per share for the quarter, beating the consensus estimate of ₹6.85 by ₹1.
Is Jubilant Pharmova Limited overvalued?
According to Wall Street analysts Jubilant Pharmova Limited’s price is currently Overvalued.
Does Jubilant Pharmova Limited pay dividends?
Jubilant Pharmova Limited pays a Annually dividend of ₹5 which represents an annual dividend yield of 0.46%. See more information on Jubilant Pharmova Limited dividends here
What is Jubilant Pharmova Limited’s EPS estimate?
Jubilant Pharmova Limited’s EPS estimate is 9.6.
How many shares outstanding does Jubilant Pharmova Limited have?
Jubilant Pharmova Limited has 159,281,140 shares outstanding.
What happened to Jubilant Pharmova Limited’s price movement after its last earnings report?
Jubilant Pharmova Limited reported an EPS of ₹7.85 in its last earnings report, beating expectations of ₹6.85. Following the earnings report the stock price went down -1.969%.
Which hedge fund is a major shareholder of Jubilant Pharmova Limited?
Currently, no hedge funds are holding shares in IN:JUBLPHARMA
Company Description
Jubilant Pharmova Limited
Jubilant Pharmova Limited (JUBLPHARMA) is a global pharmaceutical company based in India, specializing in the development and manufacturing of a wide range of pharmaceutical products, including generic formulations, radiopharmaceuticals, and active pharmaceutical ingredients (APIs). The company operates across various therapeutic areas such as oncology, cardiology, and central nervous system disorders, and is committed to providing high-quality, affordable healthcare solutions. JUBLPHARMA also engages in contract development and manufacturing services (CDMO), enabling it to cater to diverse client needs and expand its market reach.
Technical Analysis
Alembic Pharmaceuticals Limited
―
Caplin Point Laboratories Limited
―
Granules India Limited
―
NATCO Pharma Limited
―
Neuland Laboratories Ltd.
―